Skip to main content
Fig. 4 | Clinical Epigenetics

Fig. 4

From: Identification and validation of SRY-box containing gene family member SOX30 methylation as a prognostic and predictive biomarker in myeloid malignancies

Fig. 4

SOX30 methylation as a predictive biomarker in monitoring disease recurrence in AML. a SOX30 methylation level in AML patients of different clinical stages. SOX30 methylation level was examined by RQ-MSP. **: P < 0.01; ***: P < 0.001. b Dynamic changes of SOX30 methylation level in paired patients of different clinical stages when compared individually

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us